229000.KQ
Gencurix Inc.
KOE · Healthcare · Medical - Specialties · KR
KRW 1,852.00
+0.11%Year over year
Reported trailing growth
- Revenue
- +19.7%
- EBITDA
- -50.0%
- EBIT
- -37.2%
- EPS
- —
- Free cash flow
- +46.5%
- Operating cash flow
- +45.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +43.4%
- EBITDA
- —
- EBIT
- +13.8%
- Net income
- -78.1%
- EPS
- -67.8%
- Free cash flow
- +20.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026